Smoking affects eotaxin levels in asthma patients

Journal of Asthma

Volumn 46, Issue 5, 2009, Pages 470-476

  Krisiukeniene, Algirda ^a   Babusyte, Agne ^a   Stravinskaite, Kristina ^a   Lotvall, Jan ^b   Sakalauskas, Raimundas ^a   Sitkauskiene, Brigita ^a,c  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NONE   (Lithuania)

Author keywords

Asthma; Eotaxin 1; Eotaxin 2; Eotaxin 3; IL 5; Smoking

Indexed keywords

CYTOKINE; EOTAXIN; EOTAXIN 2; EOTAXIN 3; INTERLEUKIN 5; BETA CHEMOKINE; CCL26 PROTEIN, HUMAN;

ADULT; AIRWAY; ARTICLE; ASTHMA; BLOOD SAMPLING; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LEUKOCYTE DIFFERENTIAL COUNT; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; SPIROMETER; SPUTUM ANALYSIS; CHEMISTRY; MIDDLE AGED; SMOKING; SPUTUM;

ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CCL11; CHEMOKINE CCL24; CHEMOKINES, CC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-5; MALE; MIDDLE AGED; SMOKING; SPUTUM;

EID: 67650293890     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900902846349     Document Type: Article

References (33)

1. Global Strategy for Asthma Management and Prevention. NIH publication No. 02-3659. Global Initiative for Asthma. National Institutes of Health. National Heart, Lung and Blood Institute, 2002 (updated 2007).
2. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola A. Asthma. From bronchoconstriction to inflammation and remodeling. Am J Respir Crit Care Med 2000; 161:1720-1745.
3. Holgate ST. Pathogenesis of asthma. Clin Exp Allergy 2008; 38:872-897.
4. Bandeira-Melo Ch, Herbst A, Weller PF. Eotaxins. Contributing to the diversity of eosinophil recruitment and activation. Am J Respir Cell Mol Biol 2001; 24:653-657.
5. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF. Troung O, Hsuan JJ, Williams TJ. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994; 179:881-887.
6. Patel VP, Kreider BL, Li Y, Li H, Leung K, Salcedo T, Nardelli B, Pippalla V, Gentz S, Thotakura R, Parmelee D, Gentz R, Garotta G. Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med 1997; 185:1163-1172.
7. Palframan RT, Collins PD, Williams TJ, Rankin SM. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 1998; 91:2240-2248.
8. Ravensberg AJ, Ricciardolo FLM, van Schadewijk A, Rabe KF, Sterk PJ, Hiemstra PS, Mauad T. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. J Allergy Clin Immunol 2005; 115:779-785.
9. Siroux V, Pin I, Oryszczyn MP, Le Moual N, Kauffman F. Relationships of active smoking to asthma and asthma severity in the EGEA study. Eur Respir J 2000; 15:470-477.
10. Floreani A, Rennard S. The role of cigarette smoke in the pathogenesis of asthma and as a trigger for acute symptoms. Curr Opin Pulm Med 1999; 5:38-46.
11. Rahman I, McNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 1996; 51:348-350.
12. Sitkauskiene B, Krisiukeniene A, Sakalauskas R. Difficult/therapy resistant asthma: Pathogenesis and possible relationship with tobacco smoke. Current Respiratory Medicine Reviews 2006; 2:67-74.
13. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party. Standartization of lung function tests. European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6:5-40.
14. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Debburg JA and Hargreave FE. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47:25-29.
15. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovic R, Maestrelli P, Sterk PJ. Sputum induction. Eur Resp J 2002; 20 (suppl 37):3s-8.
16. Popov TA, Pizzichini MM, Pizzichini E, Kolendowicz R, Punthakee Z, Dolovich J, Hargreave FE. Some technical factors influencing the induction of sputum for cell analysis. Eur Resp J 1995; 8:559-565.
17. Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli VM, Craig TJ, Drazen JM, Ford JG, Fish JE, Israel E, Kraft M, Lemanske RF, Martin RJ, McLean D, Peters SP, Sorkness C, Szefler SJ. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001; 163:1470-1475.
18. Kips JC, Fahy JV and Hargreave FE. Methods of sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma. Eur Resp J 1998; 11:9s-12s.
19. Keatings VM, Evans DJ, O'Connor BJ, Barnes PJ. Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. Thorax 1997; 52:372-374.
20. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158:1277-1285.
21. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003; 168:1308-1311.
22. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004; 24:822-833.
23. Oltmanns U, Chung KF, Salters M, John M, Mitchell JA. Cigarette smoke induces IL-8, but inhibits eotaxin and RANTES release from airway smooth muscle. Respir Res 2005; 6:74-84.
24. Kubo S, Kobayashi M, Masunaga Y, Ishii H, Hirano Y, Takahashi K, Shimizu Y. Cytokine and chemokine expression in cigarette smoke-induced lung injury in guinea pigs. Eur Respir J 2005; 26:993-1001.
25. Yamamoto K, Takanashi S, Hasegawa Y, Kanehira Y, Kaizuka M, Okumura K. Eotaxin level in induced sputum is increased in patients with bronchial asthma and in smokers. Respiration 2003; 70:600-605.
26. Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions and antagonism. Annu Rev Immunol 2007; 25:787-820.
27. Van Wetering S, Zuyderduyn S, Ninaber DK, van Sterkenburg MA, Rabe KF, Hiemstra PS. Epithelial differentiation is a determinant in the production of eotaxin-2 and -3 by bronchial epithelial cells in response to IL-4 and IL-13. Mol Immunol 2007; 44:803-811.
28. Min GM, Song DJ, Miller M, Cho JY, McElwain S, Ferguson P, Broide DH. Coexposure to environmental tobacco smoke increases levels of allergen-induced airway remodeling in mice. The Journal of Immunology 2007; 178:5321-5328.
29. Moerloose KB, Pauwels A, Joos GF. Short-term cigarette smoke exposure enhances allergic airway inflammation in mice. AM J Respir Crit Care Med 2005; 172:168-172.
30. Yang M, Hogan SP, Mahalingam S, Pope SM, Zimmermann N, Fulkerson P, Dent LA, Young I, |Matthaei KI, Rothenberg ME, Foster PS. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J Allergy Clin Immunol 2003; 112:935- 943.
31. Moerloose KB, Robays LJ, Maes T, Brusselle GG, Tournoy KG, Joos GF. Cigarette smoke exposure facilitates allergic sensitization in mice. Respir Res 2006; 7: 49.
32. Menies-Gow A, Ying S, Sabroe I, Stulbs VL, Soler D, Williams TJ, Kay B A. Eotaxin (CCL11) and eotaxin-2 (CCL-24) induce recruitment of eosinophils, basophils, neutrophils and macrophages as following cutaneous injection in human atopic and non atopic volunteers. The Journal of Immunology 2002; 169:2712-2718.
33. Bumbacea D, Scheerens J, Mann BS, Stirling RG, Chung KF. Failure of sputum eosinophilia after eotaxin inhalation in asthma. Thorax 2004; 59:372-375.